Relation between urinary androgen and corticoid excretion and subsequent breast cancer.

Bulbrook, R.D.; Hayward, J.L.; Spicer, C.C.

doi:10.1016/s0140-6736(71)90113-9

Cited by 221Estrogen and related hormone effectsCancer Risks and FactorsAdrenal Hormones and Disorders

Relation between urinary androgen and corticoid excretion and subsequent breast cancer.

Bulbrook, R.D., Hayward, J.L., Spicer, C.C.·1971·The Lancet

DOI 10.1016/s0140-6736(71)90113-9

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(71)90113-9

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Epidemiological studies have generally observed a protective effect of DHEA on breast cancer, especially in Western women.
“Epidemiological studies have generally observed a protective effect of DHEA on breast cancer, especially in Western women (191,193,281,282).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [191]

ŒSTROGEN FRACTIONS DURING EARLY REPRODUCTIVE LIFE IN THE ÆTIOLOGY OF BREAST CANCER
Cole, P. T., & MacMahon, B. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91537-2 · Cited by 171 · see citing works
ABNORMAL URINARY STEROID EXCRETION AND SUBSEQUENT BREAST CANCER
Bulbrook, R. D., & Hayward, J. L. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92107-1 · Cited by 117 · see citing works
Self-citation
Abnormal excretion of urinary steroids by women with early breast cancer.
Bulbrook, R. D., Hayward, J. L., Spicer, C. C., & Thomas, B. S. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92812-x · Cited by 105 · see citing works
Self-citation
A COMPARISON BETWEEN THE URINARY STEROID EXCRETION OF NORMAL WOMEN AND WOMEN WITH ADVANCED BREAST CANCER
Bulbrook, R. D., Hayward, J. L., Spicer, C. C., & Thomas, B. S. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92811-8 · Cited by 89 · see citing works
Self-citation
Hormone Excretion Patterns in Breast and Prostate Cancer Are Abnormal
Stern, E., Hopkins, C. E., Weiner, J. M., & Marmorston, J. (1964) · Science · doi:10.1126/science.145.3633.716 · Cited by 46 · see citing works
Benign and malignant breast disease in south Wales: a study of urinary steroids.
Cameron, E. H. D., Griffiths, K., Gleave, E. N., Stewart, H. J., Forrest, A. P. M., & Campbell, H. (1970) · BMJ · doi:10.1136/bmj.4.5738.768 · Cited by 38 · see citing works
DETERMINATION OF SOLVOLYSED SULPHATE ESTERS OF DEHYDROEPIANDROSTERONE AND ANDROSTERONE IN HUMAN PERIPHERAL PLASMA BY GAS-LIQUID CHROMATOGRAPHY
Wang, D. Y., Bulbrook, R. D., Thomas, B. S., & Friedman, M. (1968) · Journal of Endocrinology · doi:10.1677/joe.0.0420567 · Cited by 31 · see citing works
Self-citation
THE DISCRIMINANT FUNCTION IN EARLY CARCINOMA OF THE BREAST
Wade, A. P., Davis, J. C., Tweedie, M. C. K., Clarke, C. A., & Haggart, B. G. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91899-6 · Cited by 29 · see citing works
A CORRELATION BETWEEN URINARY STEROID METABOLITES AND PATHWAYS OF STEROIDOGENESIS IN HUMAN BREAST-TUMOUR TISSUE
Adams, J. B., & Wong, M. S. F. (1968) · The Lancet · doi:10.1016/s0140-6736(68)91640-1 · Cited by 16 · see citing works
The value of urine steroid hormone assays in breastcancer
Miller, H., & Durant, J. A. (1967) · Clinical Biochemistry · doi:10.1016/s0009-9120(67)80034-1 · Cited by 13 · see citing works

Flagged first, then by citations

Sorted by citations

Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349 · see citing works
Differentiation of the mammary gland and susceptibility to carcinogenesis
Russo, J., Tay, L. K., & Russo, I. H. (1982) · Breast Cancer Research and Treatment · doi:10.1007/bf01805718 · Cited by 628 · see citing works
Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544 · see citing works
Hormones and the physiological architecture of life history evolution
Finch, C. E., & Rose, M. R. (1995) · The Quarterly Review of Biology · doi:10.1086/418864 · Cited by 376 · see citing works
Serum Sex Hormone Levels After Menopause and Subsequent Breast Cancer
Berrino, F., Muti, P. C., Micheli, A., BOLELLI, G., Krogh, V., Sciajno, R., Pisani, P., Panico, S., & Secreto, G. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.291 · Cited by 335 · see citing works
Early Menarche, a Risk Factor for Breast Cancer, Indicates Early Onset of Ovulatory Cycles*
APTER, D., & VIHKO, R. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-1-82 · Cited by 323 · see citing works
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311 · see citing works
Nutrition and its Relationship to Cancer
Reddy, B. S., Cohen, L. A., McCoy, G. D., Hill, P., Weisburger, J. H., & Wynder, E. L. (1980) · Advances in cancer research · doi:10.1016/s0065-230x(08)60363-2 · Cited by 248 · see citing works
Premorbid psychological factors as related to cancer incidence
Fox, B. H. (1978) · Journal of Behavioral Medicine · doi:10.1007/bf00846586 · Cited by 234 · see citing works
Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
Rao, C. V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G. J., & Reddy, B. S. (1991) · PubMed · Cited by 190 · see citing works
Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer
Wald, N., Bouman, A. I. E., & Hudson, G. R. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.49 · Cited by 175 · see citing works
Conference summary: assessing oral health outcomes--measuring health status and quality of life.
Slade, G. D., Strauss, R. P., Atchison, K. A., Kressin, N. R., Locker, D., & Reisine, S. (1998) · PubMed · Cited by 170 · see citing works
Steroid-hormone receptors in breast cancer
Wittliff, J. L. (1984) · Cancer · doi:10.1002/1097-0142(19840201)53:3+ · Cited by 323 · see citing works
Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.
Gordon, G. B., Shantz, L. M., & Talalay, P. (1987) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(87)90023-9 · Cited by 159 · see citing works
Inadequate corpus luteum function: A pathophysiological interpretation of human breast cancer epidemiology
Sherman, B. M., & Korenman, S. G. (1974) · Cancer · doi:10.1002/1097-0142(197405)33:5 · Cited by 140 · see citing works
Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)
Manjer, J., Johansson, R., Berglund, G. L., Janzon, L., Kaaks, R., Ågren, Å., & Lenner, P. (2003) · Cancer Causes & Control · doi:10.1023/a:1025671317220 · Cited by 125 · see citing works
Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone
Nyce, J. W., MAGEE, P. N., Hard, G. C., & Schwartz, A. G. (1984) · Carcinogenesis · doi:10.1093/carcin/5.1.57 · Cited by 125 · see citing works
Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer.
Zumoff, B., Levin, J., Rosenfeld, R. S., Markham, M. J., Strain, G. W., & Fukushima, D. K. (1981) · PubMed · Cited by 123 · see citing works
Relation of Serum Levels of Testosterone and Dehydroepiandrosterone Sulfate to Risk of Breast Cancer in Postmenopausal Women
Zeleniuch‐Jacquotte, A., Bruning, P. F., Bonfrèr, J. M. G., Koenig, K. L., Shore, R. E., Kirn, M., Pasternack, B. S., & Toniolo, P. G. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009059 · Cited by 115 · see citing works
The estrogenic and antiestrogenic activities of androgens in female target tissues.
Rochefort, H., & Garcia, M. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90013-x · Cited by 107 · see citing works
Inhibition of tumor development by dehydroepiandrosterone and related steroids.
Schwartz, A. G., Pashko, L., & Whitcomb, J. M. (1986) · Toxicologic Pathology · doi:10.1177/019262338601400312 · Cited by 101 · see citing works
ŒSTROGEN PROFILES OF ASIAN AND NORTH AMERICAN WOMEN
MacMahon, B., Cole, P. T., Brown, J. B., Aoki, K., Lin, T., Morgan, R., & Woo, N. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92504-9 · Cited by 97 · see citing works
Dehydroepiandrosterone Research: Past, Current, and Future
Klinge, C. M., Clark, B. J., & Prough, R. A. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.02.002 · Cited by 97 · see citing works
Effect of Dehydroepiandrosterone on Growth in Lean and Obese Zucker Rats
Cleary, M. P., Shepherd, A., & Jenks, B. H. (1984) · Journal of Nutrition · doi:10.1093/jn/114.7.1242 · Cited by 91 · see citing works
Dehydroepiandrosterone Sulphate (DHEAS) in the Oldest Old, Aged 85 and Overa
Birkenhäger‐Gillesse, E. G., Derksen, J. J. L., & Lagaay, A. M. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56858.x · Cited by 89 · see citing works
Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydrogenase.
Shantz, L. M., Talalay, P., & Gordon, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3852 · Cited by 87 · see citing works
On some Late Effects of Bilateral Oophorectomy in the Age Range 15–30 Years
Johansson, B., Kaij, L., Kullander, S., LENNÉR, H. C., Svanberg, L., & Åstedt, B. (1975) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347509157108 · Cited by 78 · see citing works
Dehydroepiandrosterone: antiglucocorticoid action in mice.
Browne, E. S., Wright, B. E., Porter, J. R., & Svec, F. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199206000-00003 · Cited by 77 · see citing works
Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko, T. A., Detrisac, C. J., Mehta, R. G., Kelloff, G. J., & Moon, R. C. (1991) · PubMed · Cited by 75 · see citing works
Hormonal Intervention: “Buffer Hormones” or “State Dependency”
Regelson, W., Loria, R. M., & Kalimi, M. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb35284.x · Cited by 75 · see citing works
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
Kadouri, L., Easton, D. F., Edwards, S. M., Hubert, A., Kote‐Jarai, Z., Gläser, B., Durocher, F., Abeliovich, D., Peretz, T., & Eeles, R. A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1777 · Cited by 74 · see citing works
A biochemical approach to the staging of human breast cancer
Coombes, R. C., Powles, T. J., Gazet, J.-C., Ford, H. T., Nash, A. G., Sloane, J. P., Hillyard, C. J., Thomas, P. R. M., Keyser, J. W., Marcus, D. M., et al. (1977) · Cancer · doi:10.1002/1097-0142(197708)40:2 · Cited by 46 · see citing works
Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.
Li, S., Yan, X., B�langer, A., & Labrie, F. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00665681 · Cited by 70 · see citing works
Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines
Yoshida, S., Honda, A., Matsuzaki, Y., Fukushima, S., Tanaka, N., Takagiwa, A., Fujimoto, Y., Miyazaki, H., & Salen, G. (2002) · Steroids · doi:10.1016/s0039-128x(02)00117-4 · Cited by 64 · see citing works
Endogenous steroids in the pathophysiology of breast cancer
Vihko, R., Apter, D. L., & Bulbrook, R. D. (1989) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(89)80012-5 · Cited by 64 · see citing works
Self-citation
Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs
Glaser, J. L., BRIND, J. L., Vogelman∥, J. H., Eisner, M. J., Dillbeck, M. C., Wallace, R. K., Chopra, D., & Orentreich∥, N. (1992) · Journal of Behavioral Medicine · doi:10.1007/bf00844726 · Cited by 64 · see citing works
Dehydroepiandrosterone: An anti‐obesity and anti‐carcinogenic agent
Schwartz, A. G., Hard, G. C., Pashko, L. L., Abou-Gharbia, M. A., & Swern, D. (1981) · Nutrition and Cancer · doi:10.1080/01635588109513700 · Cited by 63 · see citing works
Protective effect of dehydroepiandrosterone against aflatoxin B1-and 7,12-dimethylbenz(a)anthracene-induced cytotoxicity and transformation in cultured cells.
Schwartz, A. G., & Perantoni, A. O. (1975) · PubMed · Cited by 63 · see citing works
Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells
Monaco, M. D., Pizzini, A., Gatto, V., Leonardi, L., Gallo, M., Brignardello, E., & Boccuzzi, G. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.102 · Cited by 62 · see citing works
Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats.
Schwartz, A. G., Lewbart, M. L., & Pashko, L. L. (1988) · PubMed · Cited by 60 · see citing works
The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom)
Stavola, B. L. D., Wang, D. Y., Allen, D. S., Giaconi, J., Fentiman, I. S., Reed, M. J., Bulbrook, R. D., & Hayward, J. L. (1993) · Cancer Causes & Control · doi:10.1007/bf00051335 · Cited by 59 · see citing works
Self-citation
Dehydroepiandrosterone sulfate and breast cancer risk.
Barrett-Connor, E. L., Friedlander, N. J., & Khaw, K. (1990) · PubMed · Cited by 57 · see citing works
Inhibition of the conversion of 3T3 fibroblast clones to adipocytes by dehydroepiandrosterone and related anticarcinogenic steroids.
Gordon, G., Newitt, J. A., Shantz, L. M., Weng, D. E., & Talalay, P. (1986) · PubMed · Cited by 57 · see citing works
Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer.
Gordon, G., Helzlsouer, K. J., & Comstock, G. W. (1991) · PubMed · Cited by 56 · see citing works
Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women
Grattarola, R. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)31304-1 · Cited by 56 · see citing works
Binding of oestradiol to blood proteins and aetiology of breast cancer
Moore, J. W., Clark, G. M. G., Hoare, S., Millis, R. R., Hayward, J. L., Quinlan, M. K., Wang, D. Y., & Bulbrook, R. D. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380502 · Cited by 56 · see citing works
Self-citation
Factor Analysis of Self-reported Symptoms: Does It Identify a Gulf War Syndrome?
Knoke, J. D. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.4.379 · Cited by 55 · see citing works
Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status
Honma, N., Sakamoto, G., Akiyama, F., Esaki, Y., Sawabe, M., Arai, T., Hosoi, T., Harada, N., Younes, M., & Takubo, K. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01542.x · Cited by 54 · see citing works
Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol.
Bulbrook, R. D., Herian, M., Tong, D., Hayward, J. L., Swain, M. C., & Wang, D. Y. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92198-3 · Cited by 53 · see citing works
Self-citation
Molecular and Cellular Basis of the Mammary Gland Susceptibility to Carcinogenesis
Russo, J., Tay, L. K., Ciocca, D. R., & Russo, I. H. (1983) · Environmental Health Perspectives · doi:10.1289/ehp.8349185 · Cited by 53 · see citing works
Dehydroepiandrosterone protects low density lipoproteins against peroxidation by free radicals produced by γ-radiolysis of ethanol–water mixtures
Khalil, A., Lehoux, J., Wagner, J. R., Lesur, O., Cruz, S., Dupont, É., Jay‐Gerin, J., Wallach, J., & Fülöp, T. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00194-9 · Cited by 53 · see citing works
Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats.
Prough, R. A., Webb, S. J., Wu, H. Q., Lapenson, D. P., & Waxman, D. J. (1994) · PubMed · Cited by 53 · see citing works
Plasma levels of C-19 steroids and 5α-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women
Brochu, M., Bélanger, A., & Tremblay, R. R. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59589-2 · Cited by 52 · see citing works
The Effect of Dehydroepiandrosterone on Liver Metabolites
Casazza, J. P., Schaffer, W. T., & Veech, R. L. (1986) · Journal of Nutrition · doi:10.1093/jn/116.2.304 · Cited by 48 · see citing works
Low serum testosterone concentrations in patients with carcinoma of the pancreas
Greenway, B., Iqbal, M. J., Johnson, P. J., & Williams, R. L. (1983) · BMJ · doi:10.1136/bmj.286.6359.93 · Cited by 47 · see citing works
Determinants of the Availability and Accuracy of Self-reported Birth Weight in Middle-aged and Elderly Women
Allen, D. S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.379 · Cited by 46 · see citing works
Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer
Bulbrook, R. D., Moore, J. W., Clark, G. M. G., Wang, D. Y., Tong, D., & Hayward, J. L. (1978) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(78)90120-2 · Cited by 46 · see citing works
Self-citation
Androgens in postmenopausal breast cancer: Excretion, production and interaction with estrogens
Thijssen, J. H. H., Poortman, J., & Schwarz, F. (1975) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(75)90060-6 · Cited by 45 · see citing works
The effects of dehydroepiandrosterone on carcinogenesis, obesity, the immune system, and aging
Williams, J. R. (2000) · Lipids · doi:10.1007/s11745-000-0529-7 · Cited by 44 · see citing works
The relation between radiographic features and determinants of risk of breast cancer
Gravelle, I. H., Bulstrode, J. C., Wang, D. Y., Bulbrook, R. D., & Hayward, J. L. (1980) · British Journal of Radiology · doi:10.1259/0007-1285-53-626-107 · Cited by 44 · see citing works
Self-citation
True
Wang, D. Y., Reed, M. J., Allen, D. S., Bulbrook, R. D., Thomas, B. S., Hayward, J. L., Stavola, B. L. D., Fentiman, I. S., & Brussen, J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1180 · Cited by 43 · see citing works
Self-citation
Multiple primary cancers of the breast and ovary
Prior, P., & Waterhouse, J. A. (1981) · British Journal of Cancer · doi:10.1038/bjc.1981.247 · Cited by 43 · see citing works
Human fetal adrenal hydroxysteroid sulphotransferase: cDNA cloning, stable expression in V79 cells and functional characterisation of the expressed enzyme
Forbes, K. J., Hagen, M., Glatt, H. R., Hume, R., & Coughtrie, M. W. H. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03585-u · Cited by 43 · see citing works
Endocrine ,neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women
Stomati, M., Rubino, S., Spinetti, A., Parrini, D., Luisi, S. V., Casarosa, E., Petraglia, F., & Genazzani, A. R. (1999) · Gynecological Endocrinology · doi:10.1080/09513599909167527 · Cited by 41 · see citing works
A prospective study of mammographic parenchymal patterns and risk of breast cancer
Gravelle, I. H., Bulstrode, J. C., Bulbrook, R. D., Wang, D. Y., Allen, D., & Hayward, J. L. (1986) · British Journal of Radiology · doi:10.1259/0007-1285-59-701-487 · Cited by 42 · see citing works
Self-citation
URINARY AND PLASMA ANDROGENS IN BENIGN BREAST DISEASE
Brennan, M. J., Bulbrook, R. D., Deshpande, N., Wang, D. Y., & Hayward, J. L. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90393-0 · Cited by 41 · see citing works
Self-citation
Diet and breast cancer: a review
Hankin, J. H., & Rawlings, V. (1978) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/31.11.2005 · Cited by 40 · see citing works
Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
Lubet, R., Gordon, G., Prough, R. A., Lei, X.-D., You, M., Wang, Y., Grubbs, C. J., Steele, V. E., Kelloff, G. J., Thomas, C. F., et al. (1998) · PubMed · Cited by 40 · see citing works
Dehydroepiandrosterone, androgens and the mammary gland
Labrie, F. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600624440 · Cited by 39 · see citing works
Endocrine status in normal British, Japanese and Hawaiian-Japanese women
Hayward, J. L., Greenwood, F. C., Glober, G. A., Stemmerman, G. N., Bulbrook, R. D., Wang, D. Y., & Kumaokas, S. (1978) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(78)90228-1 · Cited by 39 · see citing works
Self-citation
Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast
Secreto, G., Fariselli, G., Bandieramonte, G., Recchione, C., Dati, V., & Pietro, S. D. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90389-9 · Cited by 39 · see citing works
Plasma dehydroepiandrosterone sulfate, androstenedione and cortisol, and urinary free cortisol excretion in breast cancer
Rose, D. P., Stauber, P. M., Thiel, A. R., Crowley, J. J., & Milbrath, J. R. (1977) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(77)90228-6 · Cited by 39 · see citing works
Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride
Aragno, M., Tamagno, E., Boccuzzi, G., Brignardello, E., Chiarpotto, E., Pizzini, A., & Danni, O. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90572-e · Cited by 38 · see citing works
Food intake reduction and immunologic alterations in mice fed dehydroepiandrosterone
Weindruch, R. H., Mcfeeters, G., & Walford, R. L. (1984) · Experimental Gerontology · doi:10.1016/0531-5565(84)90002-0 · Cited by 38 · see citing works
Uptake and concentration of steroid hormones in mammary tissues.
THIJSSEN, J. H. H., LANDEGHEM, A. A. J. V., & POORTMAN, J. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb15998.x · Cited by 37 · see citing works
Male breast cancer—II
Scheike, O., Svenstrup, B., & Frandsen, V. A. (1973) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(73)90064-2 · Cited by 37 · see citing works
Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo
Melvin, W. S., Boros, L. G., Muscarella, P., Brandes, J. L., Johnson, J. A., Fisher, W. E., Schirmer, W. J., & Ellison, E. C. (1997) · Surgery · doi:10.1016/s0039-6060(97)90308-1 · Cited by 36 · see citing works
Studies on the sulphate esters of dehydroepiandrosterone and androsterone in the blood of women with breast cancer
Wang, D. Y., Bulbrook, R. D., Herian, M., & Hayward, J. L. (1974) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(74)90069-3 · Cited by 36 · see citing works
Self-citation
The proliferative effects of 5-androstene-3β,17β-diol and 5α-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines
Aspinall, S. R., Stamp, S., Davison, A., Shenton, B. K., & Lennard, T. W. J. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.10.011 · Cited by 34 · see citing works
5-En-androstene-3 β,17 β-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol
Boccuzzi, G., Brignardello, E., Monaco, M. D., Gatto, V., Leonardi, L., Pizzini, A., & Gallo, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.444 · Cited by 34 · see citing works
Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism
Shilkaitis, A. L., Green, A., Punj, V., Steele, V. E., Lubet, R. A., & Christov, K. T. (2005) · Breast Cancer Research · doi:10.1186/bcr1350 · Cited by 33 · see citing works
Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat.
Luo, S., Labrie, C., Bélanger, A., & Labrie, F. (1997) · Endocrinology · doi:10.1210/endo.138.8.5345 · Cited by 34 · see citing works
Newborn Macrosomy And Cancer
Berstein, L. M. (1988) · Advances in cancer research · doi:10.1016/s0065-230x(08)60439-x · Cited by 31 · see citing works
Plasma dehydroepiandrosterone and androsterone sulphates, androstenedione and urinary androgen metabolites in normal British and Japanese women
Wang, D. Y., Hayward, J. L., Bulbrook, R. D., KUMAOKA, S., Takatani, O., Abe, O., & Utsunomiya, J. (1976) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(76)90060-8 · Cited by 31 · see citing works
Self-citation
The relationship between sex steroids and bone mineral content in women soon after the menopause
Spector, T. D., Thompson, P. W., Perry, L. A., McGARRIGLE, H. H. G., & Edwards, A. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01733.x · Cited by 30 · see citing works
Lifelong Treatment with Oral DHEA Sulfate Does Not Preserve Immune Function, Prevent Disease, or Improve Survival in Genetically Heterogeneous Mice
Miller, R. A., & Chrisp, C. E. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01291.x · Cited by 29 · see citing works
DHEA in bone: the role in osteoporosis and fracture healing
Kirby, D. J., Buchalter, D. B., Anil, U., & Leucht, P. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00755-y · Cited by 28 · see citing works
Hormonal aspects in the causation of human breast cancer: Epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy
de Waard, F., & Thijssen, J. H. H. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.08.005 · Cited by 28 · see citing works
HORMONAL PROFILES IN WOMEN WITH BREAST CANCER
Zumoff, B. (1994) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(21)00711-7 · Cited by 28 · see citing works
Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer.
Gordon, G. B., Helzlsouer, K. J., Alberg, A. J., & Comstock, G. W. (1993) · PubMed · Cited by 27 · see citing works
Urinary and plasma androgens and their relation to familial risk of breast cancer.
Wang, D. Y., Bulbrook, R. D., & Hayward, J. L. (1975) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(75)90087-0 · Cited by 26 · see citing works
Self-citation
Plasma and urinary androgens in women with varying degrees of risk of breast cancer
Wang, D. Y., Moore, J. W., Thomas, B. S., Bulbrook, R. D., Hoare, S., Tong, D., & Hayward, J. L. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90253-6 · Cited by 25 · see citing works
Self-citation
Hormones Are Ambiguous Risk Factors for Breast Cancer
Bulbrook, R. D., & Thomas, B. S. (1989) · Acta Oncologica · doi:10.3109/02841868909092319 · Cited by 24 · see citing works
Self-citation
Dehydroepiandrosterone induced alterations in rat liver carbohydrate metabolism
Mayer, D., Weber, E., Moore, M. A., Letsch, I., Filsinger, E., & Bannasch, P. (1988) · Carcinogenesis · doi:10.1093/carcin/9.11.2039 · Cited by 24 · see citing works
Epidemiology and Natural History of Breast Cancer: Implications for the Body Weight–Breast Cancer Controversy
Morabia, A., & Wynder, E. L. (1990) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)45179-0 · Cited by 23 · see citing works
The impact of the Occupation of Guernsey 1940-1945 on breast cancer risk factors and incidence
Fentiman, I. S., Allen, D. S., & Ellison, G. T. H. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01288.x · Cited by 22 · see citing works
C19‐5‐ene Steroids in Nature
Lardy, H. A., Marwah, A. K., & Marwah, P. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71009-8 · Cited by 22 · see citing works
ŒSTRIOL AND PREVENTION OF BREAST CANCER
Lemon, H. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90353-x · Cited by 22 · see citing works
Breast cancer, genetics, and age at first pregnancy.
Lynch, H. T., Albano, W. A., Layton, M. A., Kimberling, W. J., & Lynch, J. F. (1984) · Journal of Medical Genetics · doi:10.1136/jmg.21.2.96 · Cited by 22 · see citing works
Patient risk factors and the detection of early cancer
Schottenfeld, D. (1972) · Preventive Medicine · doi:10.1016/0091-7435(72)90006-0 · Cited by 21 · see citing works

ABNORMAL URINARY STEROID EXCRETION AND SUBSEQUENT BREAST CANCER
Bulbrook, R. D., & Hayward, J. L. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92107-1 · Cited by 117 · see citing works
Self-citation
True
Wang, D. Y., Reed, M. J., Allen, D. S., Bulbrook, R. D., Thomas, B. S., Hayward, J. L., Stavola, B. L. D., Fentiman, I. S., & Brussen, J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1180 · Cited by 43 · see citing works
Self-citation
Urinary Androgen Excretion and the Etiology of Breast Cancer 1
Bulbrook, R. D. (1972) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/48.4.1039 · Cited by 13 · see citing works
Self-citation
Hormones in the Aetiology and Clinical Course of Breast Cancer
Wang, D. Y., Swain, M. C., Hayward, J. L., & Bulbrook, R. D. (1972) · Springer eBooks · doi:10.1007/978-3-662-41032-5_18
Self-citation
Increased urinary androgen excretion is a hormonal abnormality detectable before the clinical onset of breast cancer.
Secreto, G., Recchione, C., Grignolio, E., & Cavalleri, A. (1983) · PubMed · Cited by 6 · see citing works

Authors: Bulbrook, R. D., Hayward, J. L., & Spicer, C. C.
Affiliations: Guy's Hospital (GB)
Medical Research Council (GB)
Venue: The Lancet
Publisher: Elsevier BV
Published: 1971-08
Volume: 298
Issue: 7721
Pages: 395-398
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(71)90113-9
OpenAlex: W2054644728
Cited by: 221
References: 10
Citations by year: 2026: 1 · 2020: 2 · 2018: 1 · 2014: 1
FWCI: 11.34
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords: breast cancer, urinary androgens, androsterone, etiocholanolone, corticosteroids, androgen metabolites, breast cancer screening, women, premenopausal women
MeSH terms: Adrenal Cortex Hormones, Adult, Age Factors, Androgens, Body Height, Body Weight, Breast Neoplasms, Etiocholanolone, Female, United Kingdom, Humans, Middle Aged, Parity, Precancerous Conditions, Time Factors, 17-Hydroxycorticosteroids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Relation between urinary androgen and corticoid excretion and subsequent breast cancer.

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks